Direct Integration of Anti-CD19 Chimeric-Antigen-Receptor (CAR) T Cells Early after Post-Transplantation Cyclophosphamide (PTCy) in Murine MHC-Haploidentical Hematopoietic Cell Transplantation (HCT) Exerts Anti-Tumor Effects without Causing Graft-Versus-Host Disease (GVHD) | Zendy

Michael T. Patterson | Zendy; Suresh K. Mendu | Zendy; Michael Eckhaus | Zendy; Rochelle Fletcher | Zendy; Natália Schneider | Zendy; Kazusa Ishii | Zendy; Haiying Qin | Zendy; Terry J. Fry | Zendy; Christopher G. Kanakry | Zendy

Open Access

Direct Integration of Anti-CD19 Chimeric-Antigen-Receptor (CAR) T Cells Early after Post-Transplantation Cyclophosphamide (PTCy) in Murine MHC-Haploidentical Hematopoietic Cell Transplantation (HCT) Exerts Anti-Tumor Effects without Causing Graft-Versus-Host Disease (GVHD)

Author(s) -

Michael T. Patterson,

Suresh K. Mendu,

Michael Eckhaus,

Rochelle Fletcher,

Natália Schneider,

Kazusa Ishii,

Haiying Qin,

Terry J. Fry,

Christopher G. Kanakry

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.032

Subject(s) - medicine , leukemia , t cell , cd19 , immunology , cyclophosphamide , cancer research , transplantation , cd28 , cd8 , haematopoiesis , antigen , immune system , stem cell , biology , chemotherapy , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research